Skip to main content
SpringerLink
Log in

Current Thoughts in Fungal Keratitis: Diagnosis and Treatment

  • Clinical Lab Issues (M Brandt, Section Editor)
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Fungal keratitis remains a challenging and often elusive diagnosis in geographic regions where it is endemic. Marred by delays in diagnosis, the sequelae of corneal fungal infections, though preventable, can be irreversible. Recent studies and advances in the arena have broadened the approach and treatment to mycotic keratitis. This review will discuss current diagnostic modalities of fungal keratitis and will particularly focus on treatment regimens. It will also explore future therapeutic models and critique the potential benefit of each.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J. 1997;23:275–81.

    PubMed  CAS  Google Scholar 

  2. • Sharma N, Chacko J, Velpandian T, et al. Comparative Evaluation of Topical versus Intrastromal Voriconazole as an Adjunct to Natamycin in Recalcitrant Fungal Keratitis. Ophthalmology 2012. Important trial that compared topical and intrastromal voriconazole in adjunct to natamycin. Showed no significant difference between topical and intrastromal voriconazole in best corrected visual acuity.

  3. Bharathi MJ, Ramakrishnan R, Meenakshi R, Padmavathy S, Shivakumar C, Srinivasan M. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007;14:61–9.

    Article  PubMed  Google Scholar 

  4. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002;86:1211–5.

    Article  PubMed  CAS  Google Scholar 

  5. Sharma S. Diagnosis of fungal keratitis: current options. Expert Opin Med Diagn. 2012;6:449–55.

    Article  PubMed  CAS  Google Scholar 

  6. Hamrah P, Dana MR. Corneal antigen-presenting cells. Chem Immunol Allergy. 2007;92:58–70.

    Article  PubMed  CAS  Google Scholar 

  7. Tarabishy AB, Aldabagh B, Sun Y, et al. MyD88 regulation of Fusarium keratitis is dependent on TLR4 and IL-1R1 but not TLR2. J Immunol. 2008;181:593–600.

    PubMed  CAS  Google Scholar 

  8. Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect. 2013;19:210–20.

    Article  PubMed  CAS  Google Scholar 

  9. Sun RL, Jones DB, Wilhelmus KR. Clinical characteristics and outcome of Candida keratitis. Am J Ophthalmol. 2007;143:1043–5.

    Article  PubMed  Google Scholar 

  10. Gower EW, Keay LJ, Oechsler RA, et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology. 2010;117:2263–7.

    Article  PubMed  Google Scholar 

  11. •• Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea. 2002;21:555–9. This review presented the epidemiological features and laboratory results of the largest series of fungal keratitis ever reported in literature. Identified demographic features and risk factors that contributed to our knowledge of how FK is aquired.

    Article  PubMed  Google Scholar 

  12. Sirikul T, Prabriputaloong T, Smathivat A, Chuck RS, Vongthongsri A. Predisposing factors and etiologic diagnosis of ulcerative keratitis. Cornea. 2008;27:283–7.

    Article  PubMed  Google Scholar 

  13. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol. 1997;81:965–71.

    Article  PubMed  CAS  Google Scholar 

  14. Foster CS. Fungal keratitis. Infect Dis Clin North Am. 1992;6:851–7.

    PubMed  CAS  Google Scholar 

  15. Pepose JS, Wilhelmus KR. Divergent approaches to the management of corneal ulcers. Am J Ophthalmol. 1992;114:630–2.

    PubMed  CAS  Google Scholar 

  16. Chin GN, Hyndiuk RA, Kwasny GP, Schultz RO. Keratomycosis in Wisconsin. Am J Ophthalmol. 1975;79:121–5.

    PubMed  CAS  Google Scholar 

  17. Doughman DJ, Leavenworth NM, Campbell RC, Lindstrom RL. Fungal keratitis at the University of Minnesota: 1971–1981. Trans Am Ophthalmol Soc. 1982;80:235–47.

    PubMed  CAS  Google Scholar 

  18. Jones DB, Sexton R, Rebell G. Mycotic keratitis in South Florida: a review of thirty-nine cases. Trans Ophthalmol Soc U K. 1970;89:781–97.

    PubMed  CAS  Google Scholar 

  19. Rosa Jr RH, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology. 1994;101:1005–13.

    PubMed  Google Scholar 

  20. Bullock JD, Elder BL, Khamis HJ, Warwar RE. Effects of time, temperature, and storage container on the growth of Fusarium species: implications for the worldwide Fusarium keratitis epidemic of 2004–2006. Arch Ophthalmol. 2011;129:133–6.

    Article  PubMed  Google Scholar 

  21. Jones BR. Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. Am J Ophthalmol. 1975;79:719–51.

    PubMed  CAS  Google Scholar 

  22. Dahlgren MA, Lingappan A, Wilhelmus KR. The clinical diagnosis of microbial keratitis. Am J Ophthalmol. 2007;143:940–4.

    Article  PubMed  Google Scholar 

  23. •• Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010;128:672–8. Important study that compared the use of natamycin and voriconazole in fungal keratitis, and to establish voriconazole as a worthy agent in FK.

    Article  PubMed  CAS  Google Scholar 

  24. McLeod SD, Kolahdouz-Isfahani A, Rostamian K, Flowers CW, Lee PP, McDonnell PJ. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology. 1996;103:23–8.

    PubMed  CAS  Google Scholar 

  25. Zhang W, Yang H, Jiang L, Han L, Wang L. Use of potassium hydroxide, Giemsa and calcofluor white staining techniques in the microscopic evaluation of corneal scrapings for diagnosis of fungal keratitis. J Int Med Res. 2010;38:1961–7.

    Article  PubMed  Google Scholar 

  26. •• Sharma S, Kunimoto DY, Gopinathan U, Athmanathan S, Garg P, Rao GN. Evaluation of corneal scraping smear examination methods in the diagnosis of bacterial and fungal keratitis: a survey of eight years of laboratory experience. Cornea. 2002;21:643–7. Determined the sensitivity, specificity, and predictive values of Gram and potassium hydroxide with calcofluor white stains in the diagnosis of early and advanced microbial keratitis. Found that KOH prep with calcofluor white is a reliable lab test in the diagnosis of mycotic keratitis.

    Article  PubMed  Google Scholar 

  27. McGinnis M. Laboratory handbook of medical mycology. New York: Academic Press; 1980.

    Google Scholar 

  28. Dursun D, Fernandez V, Miller D, Alfonso EC. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea. 2003;22:300–3.

    Article  PubMed  Google Scholar 

  29. Keay LJ, Gower EW, Iovieno A, et al. Clinical and microbiological characteristics of fungal keratitis in the United States, 2001–2007: a multicenter study. Ophthalmology 2011.

  30. Ferrer C, Alio JL. Evaluation of molecular diagnosis in fungal keratitis. Ten years of experience. Journal of Ophthalmic Inflammation and Infection. 2011;1:15–22.

    Article  PubMed  CAS  Google Scholar 

  31. Erie JC, McLaren JW, Patel SV. Confocal microscopy in ophthalmology. Am J Ophthalmol. 2009;148:639–46.

    Article  PubMed  Google Scholar 

  32. • Vaddavalli PK, Garg P, Sharma S, Sangwan VS, Rao GN, Thomas R. Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis. Ophthalmology. 2011;118:29–35. Prospective, double masked study that evaluated the sensitivity, specificity, NPV and PPV of confocal microscopy. Proposed it as an accurate and reliable diagnostic modality in the diagnosis of fungal and Acanthamoeba keratitis.

    Article  PubMed  Google Scholar 

  33. Florcruz NV, Peczon I, Jr. Medical interventions for fungal keratitis. Cochrane database of systematic reviews 2008:CD004241.

  34. Yoon KC, Jeong IY, Im SK, Chae HJ, Yang SY. Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis. Cornea. 2007;26:814–8.

    Article  PubMed  Google Scholar 

  35. Thomas PA. Fungal infections of the cornea. Eye. 2003;17:852–62.

    Article  PubMed  CAS  Google Scholar 

  36. Green WR, Bennett JE, Goos RD. Ocular penetration of amphotericin B: a report of laboratory studies and a case report of postsurgical cephalosporium endophthalmitis. Arch Ophthalmol. 1965;73:769–75.

    Article  PubMed  CAS  Google Scholar 

  37. Natamycin approved--first U.S. drug for fungal keratitis. FDA Drug Bull 1978;8:37–8.

    Google Scholar 

  38. Medoff G, Kobayashi GS. Strategies in the treatment of systemic fungal infections. N Engl J Med. 1980;302:145–55.

    Article  PubMed  CAS  Google Scholar 

  39. Kalavathy CM, Parmar P, Kaliamurthy J, et al. Comparison of topical itraconazole 1 % with topical natamycin 5 % for the treatment of filamentous fungal keratitis. Cornea. 2005;24:449–52.

    Article  PubMed  CAS  Google Scholar 

  40. Tanure MA, Cohen EJ, Sudesh S, Rapuano CJ, Laibson PR. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000;19:307–12.

    Article  PubMed  CAS  Google Scholar 

  41. •• Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol. 2004;137:820–5. Experimental study that used a large microbiology database to investigate the susceptbility profile of the most common fungal pathogens in keratitis. First proposed the role of voriconazole in the therapeutic management of Candida and Aspergillus ocular infections.

    Article  PubMed  CAS  Google Scholar 

  42. Lalitha P, Shapiro BL, Srinivasan M, et al. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol. 2007;125:789–93.

    Article  PubMed  CAS  Google Scholar 

  43. Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92:871–8.

    Article  PubMed  CAS  Google Scholar 

  44. Ramakrishnan T, Constantinou M, Jhanji V, Vajpayee RB. Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis. Cornea. 2013;32:445–9.

    Article  PubMed  Google Scholar 

  45. Prajna NV, Nirmalan PK, Mahalakshmi R, Lalitha P, Srinivasan M. Concurrent use of 5 % natamycin and 2 % econazole for the management of fungal keratitis. Cornea. 2004;23:793–6.

    Article  PubMed  Google Scholar 

  46. Panda A, Sharma N, Angra SK. Topical fluconazole therapy of Candida keratitis. Cornea. 1996;15:373–5.

    Article  PubMed  CAS  Google Scholar 

  47. Rao SK, Madhavan HN, Rao G, Padmanabhan P. Fluconazole in filamentous fungal keratitis. Cornea. 1997;16:700.

    Article  PubMed  CAS  Google Scholar 

  48. Mahdy RA, Nada WM, Wageh MM. Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis. J Ocul Pharmacol Ther. 2010;26:281–5.

    Article  PubMed  CAS  Google Scholar 

  49. Sonego-Krone S, Sanchez-Di Martino D, Ayala-Lugo R, et al. Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis. Graefes Arch Clin Exp Ophthalmol. 2006;244:782–7.

    Article  PubMed  CAS  Google Scholar 

  50. Fitzsimons R, Peters AL. Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis. Am J Ophthalmol. 1986;101:605–8.

    PubMed  CAS  Google Scholar 

  51. Perez-Balbuena AL, Vanzzini-Rosano V, Valadez-Virgen Jde J, Campos-Moller X. Fusarium keratitis in Mexico. Cornea. 2009;28:626–30.

    Article  PubMed  Google Scholar 

  52. Anane S, Ben Ayed N, Malek I, et al. Keratomycosis in the area of Tunis: epidemiological data, diagnostic and therapeutic modalities. Ann Biol Clin (Paris). 2010;68:441–7.

    Google Scholar 

  53. Mahdy RA, Nada WM, Wageh MM, Kader MA, Saleh MM, Alswad MM. Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis. Cutan Ocul Toxicol. 2010;29:193–7.

    Article  PubMed  CAS  Google Scholar 

  54. Li L, Wang Z, Li R, Luo S, Sun X. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Am J Ophthalmol. 2008;146:724–8.

    Article  PubMed  CAS  Google Scholar 

  55. Xie L, Dong X, Shi W. Treatment of fungal keratitis by penetrating keratoplasty. Br J Ophthalmol. 2001;85:1070–4.

    Article  PubMed  CAS  Google Scholar 

  56. Sharma N, Agarwal P, Sinha R, Titiyal JS, Velpandian T, Vajpayee RB. Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series. Br J Ophthalmol 2011.

  57. Siatiri H, Daneshgar F, Siatiri N. Khodabande A. Cornea: The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis; 2011.

    Google Scholar 

  58. Prakash G, Sharma N, Goel M, Titiyal JS, Vajpayee RB. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol. 2008;146:56–9.

    Article  PubMed  Google Scholar 

  59. Wei LC, Tsai TC, Tsai HY, Wang CY, Shen YC. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1 % voriconazole application. Curr Eye Res. 2010;35:573–9.

    Article  PubMed  CAS  Google Scholar 

  60. •• Xie L, Zhai H, Shi W. Penetrating keratoplasty for corneal perforations in fungal keratitis. Cornea. 2007;26:158–62. Retrospective study that determined penetrating keratoplasty (PKP) an effective surgical treatment of antifungal refractory mycotic keratitis.

    Article  PubMed  Google Scholar 

  61. Garg P, Gopinathan U, Nutheti R, Rao GN. Clinical experience with N-butyl cyanoacrylate tissue adhesive in fungal keratitis. Cornea. 2003;22:405–8.

    Article  PubMed  Google Scholar 

  62. Tseng SC. Amniotic membrane transplantation for ocular surface reconstruction. Biosci Rep. 2001;21:481–9.

    Article  PubMed  CAS  Google Scholar 

  63. Chen HC, Tan HY, Hsiao CH, Huang SC, Lin KK, Ma DH. Amniotic membrane transplantation for persistent corneal ulcers and perforations in acute fungal keratitis. Cornea. 2006;25:564–72.

    Article  PubMed  Google Scholar 

  64. Bell NP, Karp CL, Alfonso EC, Schiffman J, Miller D. Effects of methylprednisolone and cyclosporine A on fungal growth in vitro. Cornea. 1999;18:306–13.

    Article  PubMed  CAS  Google Scholar 

  65. Price Jr FW, Price MO. Descemet's stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. J Refract Surg. 2005;21:339–45.

    PubMed  Google Scholar 

  66. Reddy JC, Hammersmith KM, Nagra PK, Rapuano CJ. The role of penetrating keratoplasty in the era of selective lamellar keratoplasty. Int Ophthalmol Clin. 2013;53:91–101.

    Article  PubMed  Google Scholar 

  67. Qu LJ, Xie LX. Changing indications for lamellar keratoplasty in Shandong, 1993–2008. Chin Med J (Engl). 2010;123:3268–71.

    Google Scholar 

  68. •• Xie L, Shi W, Liu Z, Li S. Lamellar keratoplasty for the treatment of fungal keratitis. Cornea. 2002;21:33–7. These studies evaluated lamellar keratoplasty as an effective surgical intervention in the setting of antifungal refractory FK.

    Article  PubMed  Google Scholar 

  69. Xie L, Zhong W, Shi W, Sun S. Spectrum of fungal keratitis in north China. Ophthalmology. 2006;113:1943–8.

    Article  PubMed  Google Scholar 

  70. Hu JZ, Xie LX. Clinical study on the recurrence of fungal keratitis after lamellar keratoplasty. [Zhonghua yan ke za zhi]. Chinese Journal of Ophthalmology. 2008;44:111–5.

    PubMed  Google Scholar 

  71. Anshu A, Parthasarathy A, Mehta JS, Htoon HM, Tan DT. Outcomes of therapeutic deep lamellar keratoplasty and penetrating keratoplasty for advanced infectious keratitis: a comparative study. Ophthalmology. 2009;116:615–23.

    Article  PubMed  Google Scholar 

  72. Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am J Ophthalmol. 2008;146:260–5.

    Article  PubMed  CAS  Google Scholar 

  73. Khairallah SH, Byrne KA, Tabbara KF. Fungal keratitis in Saudi Arabia. Doc Ophthalmol. 1992;79:269–76.

    Article  PubMed  CAS  Google Scholar 

  74. Bhartiya P, Daniell M, Constantinou M, Islam FM, Taylor HR. Fungal keratitis in Melbourne. Clin Experiment Ophthalmol. 2007;35:124–30.

    PubMed  Google Scholar 

  75. Sponsel WE, Graybill JR, Nevarez HL, Dang D. Ocular and systemic posaconazole(SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br J Ophthalmol. 2002;86:829–30.

    Article  PubMed  CAS  Google Scholar 

  76. Tu EY, McCartney DL, Beatty RF, Springer KL, Levy J, Edward D. Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592). Am J Ophthalmol. 2007;143:222–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

NIH Center Core Grant P30EY014801, RPB Unrestricted Award and Career Development Awards Dr. Galor, Department of Defense (DOD- Grant#W81XWH-09-1-0675)

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Zubair Ansari declares that he has no conflict of interest.

Darlene Miller declares that she has no conflict of interest.

Anat Galor declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Bascom Palmer Eye Institute, University of Miami, 900 NW 17th Street, Miami, FL, 33136, USA

    Zubair Ansari, Darlene Miller & Anat Galor

  2. Miami Veterans Administration Medical Center, 1201 NW 16th St, Miami, FL, 33125, USA

    Zubair Ansari & Anat Galor

  3. Marshall University Joan C. Edwards School of Medicine, 1600 Medical Center Dr., Huntington, WV, 25701, USA

    Zubair Ansari

Authors
  1. Zubair Ansari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Darlene Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anat Galor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anat Galor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ansari, Z., Miller, D. & Galor, A. Current Thoughts in Fungal Keratitis: Diagnosis and Treatment. Curr Fungal Infect Rep 7, 209–218 (2013). https://doi.org/10.1007/s12281-013-0150-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-013-0150-1

Keywords

Search

Navigation